Korean J Thorac Cardiovasc Surg.  2012 Feb;45(1):60-64.

Large Cell Neuroendocrine Carcinoma of the Thymus: A Two-Case Report

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Inha University Hospital, Inha University School of Medicine, Korea. khkim@inha.ac.kr
  • 2Department of Hematology and Oncology, Inha University Hospital, Inha University School of Medicine, Korea.
  • 3Department of Diagnostic Radiology, Inha University Hospital, Inha University School of Medicine, Korea.
  • 4Department of Pathology, Inha University Hospital, Inha University School of Medicine, Korea.

Abstract

A large cell neuroendocrine carcinoma (LCNEC) of the thymus is a very rare malignant tumor that has a very poor prognosis. The detailed clinical features of LCNEC are still unknown, including the long term prognoses and the definitive modalities of the treatment for LCNEC of the thymus. We are reporting 2 cases of an enlarged LCNEC of the thymus, both of which were diagnosed and treated by surgical resection followed by postoperative adjuvant chemoradiation therapy. Although recurrences and metastases of the LCNEC were noticed 1 and 4 years postoperatively for each case, aggressive surgical resection and adjuvant chemoradiation therapy may be helpful for a patient's long term survival.

Keyword

Tumor, malignant; Thymus; Large cell neuroendocrine carcinoma; Surgery

MeSH Terms

Carcinoma, Neuroendocrine
Neoplasm Metastasis
Prognosis
Recurrence
Thymus Gland
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr